Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
A Standard patent application filed on 15 May 2003 credited to Chakroun, Hichem

Details

Application number :

2003244646  

Application type :

Standard  

Application status :

SEALED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer  

Inventor :

Chakroun, Hichem  

Agent name :

Watermark Patent and Trade Marks Attorneys  

Address for service :

Level 2 302 Burwood Road Hawthorn VIC 3122 Australia  

Filing date :

15 May 2003  

Associated companies :

 

Applicant name :

Aventis Pharma S.A.  

Applicant address :

20, avenue Raymond Aron F-92160 Antony France  

Old name :

 

Original Source :

Go